Devyser Diagnostics AB (publ) (STO:DVYSR)
Sweden
· Delayed Price · Currency is SEK 128.50
0.00 (0.00%)
Feb 21, 2025, 5:29 PM CET
Devyser Diagnostics AB Market Cap
Devyser Diagnostics AB has a market cap or net worth of 2.13 billion as of February 21, 2025. Its market cap has increased by 53.32% in one year.
Market Cap
2.13B
Enterprise Value
2.04B
Revenue
216.90M
Ranking
n/a
PE Ratio
n/a
Stock Price
128.50
Market Cap Chart
Since December 10, 2021, Devyser Diagnostics AB's market cap has increased from 1.35B to 2.13B, an increase of 57.37%. That is a compound annual growth rate of 15.21%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 21, 2025 | 2.13B | 8.73% |
| Dec 30, 2024 | 1.96B | 52.85% |
| Dec 29, 2023 | 1.28B | 11.06% |
| Dec 30, 2022 | 1.15B | -14.36% |
| Dec 30, 2021 | 1.35B | -0.45% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Swedish Orphan Biovitrum AB | 107.29B |
| Getinge AB | 59.87B |
| Sectra AB | 46.87B |
| Camurus AB | 37.68B |
| Medicover AB | 30.25B |
| Vitrolife AB | 27.89B |
| Elekta AB | 23.02B |
| Vimian Group AB | 22.71B |